SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001615774-16-008259
Filing Date
2016-11-14
Accepted
2016-11-14 16:20:12
Documents
62
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q s104631_10q.htm 10-Q 522368
2 EXHIBIT 31-1 s104631_ex31-1.htm EX-31.1 9586
3 EXHIBIT 31-2 s104631_ex31-2.htm EX-31.2 9470
4 EXHIBIT 32-1 s104631_ex32-1.htm EX-32.1 4275
5 EXHIBIT 32-2 s104631_ex32-2.htm EX-32.2 4440
6 GRAPHIC pg20img1_10q.jpg GRAPHIC 72101
  Complete submission text file 0001615774-16-008259.txt   3501426

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE heb-20160930.xml EX-101.INS 599006
8 XBRL SCHEMA FILE heb-20160930.xsd EX-101.SCH 33128
9 XBRL CALCULATION FILE heb-20160930_cal.xml EX-101.CAL 44482
10 XBRL DEFINITION FILE heb-20160930_def.xml EX-101.DEF 182041
11 XBRL LABEL FILE heb-20160930_lab.xml EX-101.LAB 302399
12 XBRL PRESENTATION FILE heb-20160930_pre.xml EX-101.PRE 268513
Mailing Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103 215-988-0080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27072 | Film No.: 161995001
SIC: 2836 Biological Products, (No Diagnostic Substances)